NYSEHealth CareHealth Care ServicesS&P SmallCap 600
$36.19
-11.23 (-23.68%)
Close of Nov 06, 2026 · end-of-day data
AMN 8-K filings in 2026
Every material Form 8-K Amn Healthcare Services filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
AMN Healthcare reported third-quarter 2026 revenue of $717.3 million, up 13% from a year earlier, with GAAP diluted EPS of $0.83 versus $0.76 and adjusted diluted EPS of $1.16 versus $0.39. The company guided fourth-quarter revenue to $655 million to $670 million, 10-12% below the prior year, with operating margin of (0.1%) to 0.5%, so shareholders face a sharp expected slowdown after a quarter boosted by labor disruption revenue.
Q3 2026 revenue $717.3 million, up 13% year over year; GAAP net income $33.4 million
GAAP diluted EPS $0.83 vs $0.76 a year ago; adjusted diluted EPS $1.16 vs $0.39
Q3 labor disruption revenue $59 million vs $12 million in Q3 2025
Q4 2026 guidance: revenue $655-670 million, operating margin (0.1%) to 0.5%, labor disruption revenue assumed at $5 million vs $124 million in Q4 2025
At its annual meeting on May 1, 2026, AMN Healthcare shareholders elected nine directors, approved Amendment No. 1 to the AMN Healthcare 2025 Equity Plan, approved executive pay on an advisory basis, and ratified KPMG LLP as auditor for fiscal 2026. A shareholder proposal calling for an independent board chairman was not approved. The filing reports voting results and does not report financial results.
Equity plan amendment approved: 28,909,689 for and 895,750 against.
Independent board chairman proposal not approved: 7,495,013 for and 22,327,804 against.
Advisory vote on named executive officer pay approved: 22,728,186 for and 7,071,111 against.
KPMG LLP ratified as independent registered public accounting firm for the year ending December 31, 2026: 33,170,877 for and 1,064,827 against.
AMN Healthcare said director R. Jeffrey Harris will retire from the Board at the 2026 annual meeting and will not stand for re-election, stating the decision was not due to any disagreement. The Board intends to nominate Eric Palmer, former Cigna Group executive, for election at that meeting.
R. Jeffrey Harris informed the Board on January 30, 2026 of his decision to retire, effective at the 2026 annual meeting of shareholders
Harris's decision was not due to any disagreement with the Company or the Board
The Board intends to nominate Eric Palmer for election at the 2026 Annual Meeting
Palmer previously served as President and CEO of Evernorth Health Services from January 2022 to March 2025
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Amn Healthcare Services filing is on SEC EDGAR ↗. 8-K briefs of other companies →